You Searched For: Chlorobenzene-[D5]


1 054  results were found

SearchResultCount:"1054"

Sort Results

List View Easy View (new)

Rate These Search Results

Supplier: Merck
Description: α-Bromo-3-chlorotoulene, Sigma-Aldrich®

Catalog Number: (REST30035)
Supplier: Restek
Description: Mix contains: Benzene (71-43-2), Chlorobenzene (108-90-7), 1,2-Dichlorobenzene (95-50-1), 1,3-Dichlorobenzene (541-73-1), 1,4-Dichlorobenzene (106-46-7), Ethylbenzene (100-41-4), Toluene (108-88-3).
UOM: 1 * 1 mL


Catalog Number: (EHERC11351000)
Supplier: EHRENSTORFER
Description: 3-Chloroaniline
UOM: 1 * 0,5 g


Catalog Number: (EHERC11352000)
Supplier: EHRENSTORFER
Description: 4-Chloroaniline
UOM: 1 * 0,5 g


Catalog Number: (REST36284)
Supplier: Restek
Description: The United States Pharmacopeia (USP)<467> residual solvents is a widely used compendial method intended for identifying and quantifying residual solvents in drug substances, drug products, and excipients.
UOM: 1 * 1 Ampoul


Catalog Number: (BOSSBS-1325R-CY5.5)
Supplier: Bioss
Description: Cyclic AMP-dependent phosphodiesterase type D (PDE4D) family is comprise of 5 variants (PDE4D1, D2, D3, D4 and D5). One or more PDE4D subtype variants are ubiquitously present in all mammalian cells. In CNS all five PDE4D subtype variants are expressed in varying ratios and their activity is regulated in tandem with GPCRs stimulation. Peripheral tissues also exhibit differential expression of PDE4D variants. PDE4D1/D2 mRNA levels rise in response to an increase in cAMP. Short term regulation of PDE4D variants involved PKA, MAP kinases and Erk2 phosphorylation that results in rapid change in their enzymatic activities. Other regulatory mechanism involved protein protein interactions with cytoskeletal scaffolding proteins.
UOM: 1 * 100 µl


Catalog Number: (EHERC10262600)
Supplier: EHRENSTORFER
Description: Aniline-[ring-²H₅]
UOM: 1 * 0,1 g


Supplier: Merck
Description: 4-Chloroaniline, Sigma-Aldrich®

Catalog Number: (118-0360)
Supplier: GASTEC
Description: Crystal clear gas tubes with distinct colour changes.
UOM: 1 * 10 items


Catalog Number: (SIAL23310-250ML)
Supplier: Merck
Description: 2-Chloroaniline, Sigma-Aldrich®
UOM: 1 * 250 mL


Supplier: Merck
Description: Aniline-[ring-²H₅], Sigma-Aldrich®

Catalog Number: (ENZOADI905740100)
Supplier: ENZO LIFE SCIENCES
Description: Dopamine is the predominant catecholamine neurotransmitter in the mammalian brain, where it regulates locomotor, emotional, memory, and dietary intake functions, as well as peripheral roles such as hormone secretion and renal function. Dopamine receptors (D1-D5) are members of the seven transmembrane domain containing GPCR family, and are the target of several anti-psychosis and anti-Parkinsonian drugs. The D2, D3, and D4 receptors signal via coupling of Gi/Go alpha G-protein subunits to inhibit adenylyl cyclase activity and modulate cellular potassium and calcium ion channel conductance. Expression of the D2 receptor is found primarily in the brain (striatum, olfactory tubercle, and nucleus accumbens) and in the anterior and intermediate lobes of the pituitary.
UOM: 1 * 100 µG


Catalog Number: (BOSSBS-1325R)
Supplier: Bioss
Description: Cyclic AMP-dependent phosphodiesterase type D (PDE4D) family is comprise of 5 variants (PDE4D1, D2, D3, D4 and D5). One or more PDE4D subtype variants are ubiquitously present in all mammalian cells. In CNS all five PDE4D subtype variants are expressed in varying ratios and their activity is regulated in tandem with GPCRs stimulation. Peripheral tissues also exhibit differential expression of PDE4D variants. PDE4D1/D2 mRNA levels rise in response to an increase in cAMP. Short term regulation of PDE4D variants involved PKA, MAP kinases and Erk2 phosphorylation that results in rapid change in their enzymatic activities. Other regulatory mechanism involved protein protein interactions with cytoskeletal scaffolding proteins.
UOM: 1 * 100 µl


Catalog Number: (BOSSBS-1325R-CY7)
Supplier: Bioss
Description: Cyclic AMP-dependent phosphodiesterase type D (PDE4D) family is comprise of 5 variants (PDE4D1, D2, D3, D4 and D5). One or more PDE4D subtype variants are ubiquitously present in all mammalian cells. In CNS all five PDE4D subtype variants are expressed in varying ratios and their activity is regulated in tandem with GPCRs stimulation. Peripheral tissues also exhibit differential expression of PDE4D variants. PDE4D1/D2 mRNA levels rise in response to an increase in cAMP. Short term regulation of PDE4D variants involved PKA, MAP kinases and Erk2 phosphorylation that results in rapid change in their enzymatic activities. Other regulatory mechanism involved protein protein interactions with cytoskeletal scaffolding proteins.
UOM: 1 * 100 µl


Catalog Number: (BOSSBS-1325R-CY3)
Supplier: Bioss
Description: Cyclic AMP-dependent phosphodiesterase type D (PDE4D) family is comprise of 5 variants (PDE4D1, D2, D3, D4 and D5). One or more PDE4D subtype variants are ubiquitously present in all mammalian cells. In CNS all five PDE4D subtype variants are expressed in varying ratios and their activity is regulated in tandem with GPCRs stimulation. Peripheral tissues also exhibit differential expression of PDE4D variants. PDE4D1/D2 mRNA levels rise in response to an increase in cAMP. Short term regulation of PDE4D variants involved PKA, MAP kinases and Erk2 phosphorylation that results in rapid change in their enzymatic activities. Other regulatory mechanism involved protein protein interactions with cytoskeletal scaffolding proteins.
UOM: 1 * 100 µl


Catalog Number: (BOSSBS-1325R-CY5)
Supplier: Bioss
Description: Cyclic AMP-dependent phosphodiesterase type D (PDE4D) family is comprise of 5 variants (PDE4D1, D2, D3, D4 and D5). One or more PDE4D subtype variants are ubiquitously present in all mammalian cells. In CNS all five PDE4D subtype variants are expressed in varying ratios and their activity is regulated in tandem with GPCRs stimulation. Peripheral tissues also exhibit differential expression of PDE4D variants. PDE4D1/D2 mRNA levels rise in response to an increase in cAMP. Short term regulation of PDE4D variants involved PKA, MAP kinases and Erk2 phosphorylation that results in rapid change in their enzymatic activities. Other regulatory mechanism involved protein protein interactions with cytoskeletal scaffolding proteins.
UOM: 1 * 100 µl


Inquire for Price
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us at +43 1 97002 - 0.
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us at +43 1 97002 - 0.
Dual use goods can only be delivered within the European Union.
Dual use goods can only be delivered within the European Union.
This product has been blocked by your organization. Please contact your purchasing department for more information.
The original product is no longer available. The replacement shown is available.
This product is no longer available. Alternatives may be available by searching with the VWR Catalog Number listed above. If you need further assistance, please call VWR Customer Service at +43 1 97002 - 0.
305 - 320 of 1 054
no targeter for Bottom